Status:
COMPLETED
Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population
Lead Sponsor:
AstraZeneca
Conditions:
hsCRP
Eligibility:
All Genders
18+ years
Brief Summary
An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (...
Eligibility Criteria
Inclusion
- Subjects with at least one clinic visit record within the last 12 months from the date of data entry.
- Subjects with at least one hs-CRP level measured within the last 12 months from the date of data entry.
Exclusion
- Use of statins or other lipid-lowering therapies including fibrates, niacin, and bile acid sequestrants in the past 3 months prior to hsCRP measurement
- Active inflammatory diseases documented during the period of CRP measurement
- Subjects taking immunosuppressants
- Findings of chronic inflammation: arthritis, lupus, or inflammatory bowel disease
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
1700 Patients enrolled
Trial Details
Trial ID
NCT00819273
Start Date
March 1 2009
End Date
August 1 2009
Last Update
December 6 2010
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Wŏnju, Gangwon-do, South Korea
2
Research Site
Anyang-si, Gyeonggi-do, South Korea
3
Research Site
Goyang-si, Gyeonggi-do, South Korea
4
Research Site
Uijeongbu-si, Gyeonggi-do, South Korea